Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Similar documents
Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

THE CARE WE PROMISE FACTS AND FIGURES 2017

Eligibility List 2018

Annex 2 A. Regional profile: West Africa

JOINT TB AND HIV PROGRAMMING

מדינת ישראל. Tourist Visa Table

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

ANNEX 3: Country progress indicators

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget

Maternal Deaths Disproportionately High in Developing Countries

The declining value of CD4 counts for antiretroviral therapy eligibility

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

Where is the Demand? Clearing Bottlenecks to Attaining the Targets

Global Fund Mid-2013 Results

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

Epidemiology and economics: modelling the scenarios for the end of AIDS

FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL. Smoke-free. International Status Report

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

This portion to be completed by the student Return by July 1 Please use ballpoint pen

Certificate of Immunization

WHO report highlights violence against women as a global health problem of epidemic proportions

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided

GLOBAL RepORt UNAIDS RepoRt on the global AIDS epidemic

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries

3.5 Consumption Annual Prevalence Opiates

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014

STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE

Tipping the dependency

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Global Fund Results Fact Sheet Mid-2011

STAT/SOC/CSSS 221 Statistical Concepts and Methods for the Social Sciences. Introduction to Mulitple Regression

Global Fund ARV Fact Sheet 1 st June, 2009

ICM: Trade-offs in the fight against HIV/AIDS

FORMS MUST BE COMPLETED PRIOR TO THE START OF YOUR FIRST SEMESTER

Why Invest in Nutrition?

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

Supplementary appendix

TOBACCO USE PREVALENCE APPENDIX II: The following definitions are used in Table 2.1 and Table 2.3:

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

UNDERGRADUATE STUDENT HEALTH PACKET

REQUIRED COLLEGIATE START. (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION

The Global HIV/AIDS Epidemic, risk factors for transmission. and Global response. Training Course in Sexual and Reproductive Health Research 2014

O c t o b e r 1 0,

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Global Measles and Rubella Update. April 2018

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Health Services Immunization and Health Information

Student Health Center Mandatory Immunization Information

Seizures of ATS (excluding ecstasy ), 2010

The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms.

CND UNGASS FOLLOW UP

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

Dear New Student and Family,

FACTS AND FIGURES 2015 OUR VILLAGE

all incoming UWL students MUST submit an up-to-date immunization history, including vaccination dates.

STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring semester)

World Health Organization Department of Communicable Disease Surveillance and Response

Copyright 2010 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a and Fairfield

Main developments in past 24 hours

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Name DOB / / LAST FIRST MI Home Address: Street City: State: Zip: Name of Parent/Guardian(Emergency Contact) Relationship Contact Phone Number

Update: Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB

Annual prevalence estimates of cannabis use in the late 1990s

Global malaria mortality between 1980 and 2010: a systematic analysis

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

The IB Diploma Programme Statistical Bulletin. November 2015 Examination Session. Education for a better world

The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny College. Please PRINT legibly.

SUBMITTING THE MANDATORY IMMUNIZATION FORM

What is this document and who is it for?

Articles. Funding Bill & Melinda Gates Foundation.

Welcomes New Students

Global EHS Resource Center

Health Status Report

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

Financing malaria control

Health Insurance and Immunization Guide

PUBLIC HEALTH FACT SHEET

The worldwide societal costs of dementia: Estimates for 2009

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

Global Measles and Rubella Update November 2018

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Comparative Analyses of Adolescent Nutrition Indicators

WHO Global Status Report on Alcohol 2004

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

HIV and development challenges for Africa Catherine Hankins, Associate Director & Chief Scientific Adviser to UNAIDS

Insurance (required) Please attach a copy of the front and back of your current health insurance card

SEATTLE UNIVERSITY. Name. Address Street City State Zip Code. Date of Entry / Date of Birth / / School ID# M Y M D Y

Stakeholders consultation on strengthened cooperation against vaccine preventable diseases

MY.WILSON.EDU/HEALTH

Transcription:

Current State of Global HIV Care Continua Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 1) International Association of Providers of AIDS Care 2) Centers for Disease Control and Prevention Last updated: May 2017

90-90-90 and Continuum of Care Targets 90% 90% 90% Know status On treatment Virally suppressed 90% 81% 73%

Methodology Identification (216) 35 continuum identified through PubMed search 181 continuum identified through UNAIDS country reports, WHO reports, PEPFAR country operational plans, national reports, and conference papers Screening (120) 120 recent continuum selected (2010-16) Data collection (109) For 109 continuum, data were collected on the 4 key continuum indicators Methods review and data analysis (76) Each indicator was graded on methods, which was used to grade the continuum. Progress towards the 90-90-90 targets was also analyzed for the 76 continua Tripled cascades for Africa through PEPFAR open data effort: 96 older and/or duplicate continuum excluded 11 continuum that reported preliminary/ unconfirmed national figures excluded 33 continuum that did not have viral suppression estimates excluded Search end date: May 2017

People living with HIV diagnosed positive (2010-2016) UNAIDS target 90% 90%-100% 70-89% Below 70% Data not available Incomplete or no continua People living with HIV diagnosed positive (Target 90%) 76 (73% global HIV burden in 2015) with complete care continua

People living with HIV on ART (2010-2016) UNAIDS target 81% 81%-100% 60-80% Below 60% Incomplete or no continua People living with HIV on ART (Target 81%) 76 countries with complete care continua

People living with HIV with viral suppression (2010-2016) UNAIDS target 73% 73%-100% 50-72% Below 50% Incomplete or no continua People living with HIV with viral suppression (Target 73%) 76 with complete care continua

Mapping on ART and viral suppression 90-90-90 targets (76 countries) ART coverage >81% and viral suppression >73% ART coverage 60-80% and viral suppression 50-72% ART coverage <60% and viral suppression <50% Incomplete or no continua 76 countries with complete care continua

Proportion of people living with HIV diagnosed and on ART 100% 90% UNAIDS target: 81% TARGET Proportion of PLHIV on ART 80% 70% 60% 50% 40% 30% 20% 10% UNAIDS target: 90% 0% 0% 10% 20% 30% 40% 50% 60% 70% Proportion of PLHIV diagnosed 80% 90% 100% 76 countries with data on 1 st and 2 nd 90

Proportion of people living with HIV on ART and with viral suppression Proportion of PLHIV with viral suppression 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% UNAIDS target: 73% 76 countries with complete care continua UNAIDS target: 81% TARGET 0% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Proportion of PLHIV on ART

Top 21 countries reporting more than 84% of people living with diagnosed HIV (2010-2016) 101% Proportion of people living with HIV diagnosed 96% 91% 86% 81% 98% 92% 91% 90% 90% 89% 88% 88% 87% 87% 87% 87% 87% 86% 86% 86% 86% 85% 84% 84% 84% 90% 76% Romania Kazakhstan Denmark Italy Sweden Thailand Austria Netherlands Estonia Hungary Luxembourg UK US Australia Brazil 76 countries with complete care continua Japan Suriname Germany Belgium France Uzbekistan

Top 21 countries reporting more than 64% of people living with HIV on ART (2010-2016) Proportion of people living with HIV on ART 100% 81% 90% 80% 70% 60% 50% 40% Sweden 86% 85% 83% 77% 75% 75% 75% 75% 75% 75% 74% Denmark UK Netherlands Austria 76 countries with complete care continua 72% 72% 72% 71% 71% 70% 70% 66% 64% 64% Cambodia France Romania Spain Switzerland Rwanda Germany Italy Malta Japan Belgium Botswana Namibia Australia Greece Swaziland

Top 20 countries reporting more than 53% of people living with HIV with viral suppression (2010-2016) 100% Proportion of people living with HIV with viral suppression 73% 90% 80% 70% 60% 50% 40% 30% 80% 78% 78% 72% 72% 70% 70% 68% 67% 67% 66% 76 countries with complete care continua 64% 63% 62% 62% 60% 59% 57% 54% 53% Denmark Sweden UK Netherlands Switzerland Cambodia Japan France Belgium Germany Spain Rwanda Namibia Australia Malta Luxembourg Italy Austria Swaziland Kenya

Top 10 countries with >67% viral suppression (2010-2016) 100% 90% People living with HIV 80% 70% 60% 50% 40% 30% 20% 10% 0% 91% 85% 80% 90% 86% 78% 87% 83% 78% 88% 77% 72% 82% 75% 72% 83% 75% 70% 86% 71% 70% 84% 75% 68% 85% 72% 67% 84% 71% 67% Denmark* Sweden* 76 countries with complete care continua * Marked countries have high quality cascade UK Netherlands* Switzerland Cambodia Japan Diagnosed On ART Virally suppressed France Germany Belgium

Documenting and grading continua methods

ART CD4 cell count initiation for asymptomatic people (123 countries) 2015 WHO Recommendation : Irrespective of CD4 count <200, <250 or <300 <350 <500 >500 Irrespective of CD4 count Source: published policy Treat all in 47 countries (63% burden) Source: www.hivpolicywatch.org

Availability of Viral Load (55 countries) Recommended and widely available Recommended (availability unknown) Recommended with limited availability Recommended only for monitoring treatment failure No recommendation Source: www.hivpolicywatch.org

Limitations Limited to most recent care continua available in public domain---some cascades may have been missed Africa is missing complete continua due to lack of people diagnosed and viral load data Methods of estimating continua are different across countries Viral load access is limited in many settings Continua provide a snapshot but do not capture individual and cohort outcomes well

Glass is half full! Policy is changing to test and treat Countries using 90-90-90 targets Over past 6 months care continua in public domain from Africa increased 100% Some countries are close to 90-90-90 and it is only 2016 PEPFAR and Global Fund are backing test and treat and 90-90-90 Community is embracing earlier treatment

Thank you www.hivpolicywatch.org www.hiv90-90-90watch.org

People living with HIV diagnosed positive (2010-2016) UNAIDS target 90% 90%-100% 70-89% Below 70% Data not available No continua People living with HIV diagnosed positive (Target 90%) Of the 109 countries with complete or incomplete continua, data were available for 76

People living with HIV on ART (2010-2016) UNAIDS target 81% 81%-100% 60-80% Below 60% Data not available No continua People living with HIV on ART (Target 81%) Of the 109 countries with complete or incomplete continua, data were available for 102

People living with HIV with viral suppression (2010-2016) UNAIDS target 73% 73%-100% 50-72% Below 50% Data not available No continua People living with HIV with viral suppression (Target 73%) Of the 109 countries with complete or incomplete continua, data were available for 76

ART initiation criteria in Africa 2015 WHO Recommendation : Irrespective of CD4 count <200 <350 <500 Irrespective of CD4 count Source: published policy

ART initiation for asymptomatic people ART initiation criteria Irrespective of CD4 count No. of Countries 47 Consider for >500 5 500 32 People with HIV (2015) 23,100,000 (63%) 284,000 (0.8%) 9,781,000 (27%) Countries Argentina, Australia, Austria, Botswana, Brazil, Burundi, Cambodia, China, Croatia, Denmark, France, Georgia, Germany, Haiti, India, Italy, Japan, Kenya, Korea (Republic), Lao PDR, Lesotho, Malawi, Malaysia, Maldives, Mexico, Montenegro, Mozambique, Namibia, Netherlands, Norway, Papua New Guinea, Poland, Portugal, Romania, Rwanda, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Thailand, Turkey, Uganda, United Kingdom, US, Zambia, Zimbabwe Colombia, Greece, Guyana, Hong Kong, Venezuela Algeria, Bangladesh, Bhutan, Bolivia, Cameroon, Chile, Democratic Republic of Congo, Ecuador, El Salvador, Ethiopia, Fiji, Gabon, Honduras, Madagascar, Mali, Mauritania, Moldova, Myanmar, Nepal, Nigeria, Oman, Pakistan, Peru, Russia, South Sudan, Sudan, Swaziland, Tanzania, Tunisia, Ukraine, Uruguay, Viet Nam 350 (consider for CD4 500) 5 350 25 178,000 (0.5%) 2,338,600 (6%) 300 1 200 (<0.1%) Macedonia 200 (consider for CD4 350) 5 66,000 (<0.2%) Belize, Costa Rica, Finland, Guinea, Philippines Afghanistan, Angola, Benin, Burkina Faso, Canada, Cote d Ivoire, Djibouti, Dominican Republic, Ghana, Guatemala, Indonesia, Jamaica, Kazakhstan, Latvia, Marshall Islands, Morocco, Nicaragua, Niger, Panama, Paraguay, Samoa, Sierra Leone, Timor-Leste, Tuvalu, Vanuatu Belarus, Cape Verde, Cuba, Estonia, Hungary 200 3 76,500 (0.2%) Comoros, Liberia, Senegal Source: published policy